Randomized Phase III Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate: Analysis of Quality of Life and Toxicity, PCG GU 003

C. S. Thorpe, T. A. DeWees, R. S. Bhangoo, M. Petersen, J. H.C. Chang, W. F. Hartsell, C. C. Sinesi, J. C. Rwigema, S. R. Keole, V. Gondi, C. E. Vargas

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)e295
JournalInternational journal of radiation oncology, biology, physics
Volume111
Issue number3
DOIs
StatePublished - Nov 1 2021

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint

Dive into the research topics of 'Randomized Phase III Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate: Analysis of Quality of Life and Toxicity, PCG GU 003'. Together they form a unique fingerprint.

Cite this